List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #27,911 to #27,960.
- IMI → Innovative Medicines Initiative
- IMPACT → Integrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial
- IMPACT-HF → Initiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
- IMPACT II → Integrilin To Minimise Platelet Aggregation And Coronary Thrombus - II
- IMPROVE-CHF → Improved Management Of Patients With Congestive Heart Failure
- IMPROVEDD → IMPROVEDD VTE risk score
- IMPROVEDD risk score → IMPROVEDD risk score calculator
- IMPROVEDD risk score calculator → IMPROVEDD VTE risk score
- IMPROVEDD score → IMPROVEDD VTE risk score
- IMPROVED score → IMPROVEDD risk score calculator
- IMPROVE Score Calculator → IMPROVE risk score calculator
- IMPROVE and IMPROVED → IMPROVE and IMPROVEDD scores for venous thromboembolism
- IMPROVE associative score for VTE → IMPROVE score for venous thromboembolism#IMPROVE Associative Score for VTE
- IMPROVE predictive score for VTE → IMPROVE score for venous thromboembolism#IMPROVE Predictive Score for VTE
- IMPROVE risk score → IMPROVE score
- IMPROVE risk score calculator → IMPROVE VTE risk score
- IMPROVE risk score for VTE → IMPROVE score for venous thromboembolism
- IMPROVE risk score for bleeding → IMPROVE bleeding risk score
- IMPROVE risk score for venous thromboembolism → IMPROVE score for venous thromboembolism
- IMPROVE score → IMPROVE VTE risk score
- IMPROVE score for VTE → IMPROVE score for venous thromboembolism
- IMPROVE score for bleeding → IMPROVE bleeding risk score
- IMPROVE score for venous thromboembolism → IMPROVE and IMPROVEDD scores for venous thromboembolism
- IMPROVE vs IMPROEDD scores → IMPROVE and IMPROVEDD scores for venous thromboembolism
- IMPROVE vs IMPROVED → IMPROVE and IMPROVEDD scores for venous thromboembolism
- IMS → Interventional Management Of Stroke Study
- IMT → Intima-media thickness
- IN-CHF → Italian Network - Congestive Heart Failure
- INCIDENCE OF STENT THROMBOSIS IN BMS → Incidence of stent thrombosis in BMS
- INCIDENCE OF STENT THROMBOSIS IN DES → Incidence of stent thrombosis in DES
- INCOMIN → Independent Comparison Of Interferon (Betaseron V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms)
- INFECTIOUS → Infection
- INH → Isoniazid
- INJECT → International Joint Efficacy Comparison Of Thrombolytics
- INO-4212 ebola vaccine → Ebola vaccines
- INR → Prothrombin time
- INSPIRE → Adenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial
- INSYNC → Multisite Pacing As A Supplemental Treatment Of Congestive Heart Failure: The Medtronic Inc. Insync Study
- INTACT → Iressa Non–Small Cell Lung Cancer Trial Assessing Combination Treatment
- INTAMI → Integrilin In Acute Myocardial Infarction
- INTERACT → Integrilin And Enoxaparin Randomized Assessment Of Acute Coronary Syndrome Treatment
- INTERCEPT → Incomplete Infarction Trial Of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem)
- INTERHEART → A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
- INTRACORONARY MEDICATIONS → Intracoronary pharmacotherapy
- INTRATONSILLAR ABSCESS → Peritonsillar abscess
- INTRINSIC RV → Inhibition Of Unnecessary Rv Pacing With Av Search Hysteresis In Icds
- INTRO-AMI → Integrilin And Reduced Dose Of Thrombolytic In Acute Myocardial Infarction
- INTUNIV adverse reactions → Guanfacine#Adverse Reactions
- INTUNIV clinical pharmacology → Guanfacine#Pharmacology
- INTUNIV clinical studies → Guanfacine#Clinical Studies